These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21517236)

  • 21. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
    Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
    Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
    Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
    Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.
    Meng Y; Zhang C; Zhou X
    Onco Targets Ther; 2016; 9():367-76. PubMed ID: 26855585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
    Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
    Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.
    Xu XM; Ni XB; Yang GL; Luo ZG; Niu YM; Shen M
    Mol Clin Oncol; 2016 Jun; 4(6):1078-1084. PubMed ID: 27284448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of
    Qiu H; Cheng C; Wang Y; Kang M; Tang W; Chen S; Gu H; Liu C; Chen Y
    Onco Targets Ther; 2016; 9():6641-6650. PubMed ID: 27822068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
    Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
    Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.
    Talseth BA; Ashton KA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2008 Mar; 122(6):1273-7. PubMed ID: 18027856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
    Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
    Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 polymorphism and the risk of endometrial cancer.
    Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Li J; Luo F; Zhang H; Li L; Xu Y
    Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.
    Zheng M; Wan L; He X; Qi X; Liu F; Zhang DH
    World J Surg Oncol; 2015 Feb; 13():55. PubMed ID: 25888980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
    Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
    Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer.
    Krüger S; Engel C; Bier A; Mangold E; Pagenstecher C; Doeberitz Mv; Holinski-Feder E; Moeslein G; Keller G; Kunstmann E; Friedl W; Plaschke J; Rüschoff J; Schackert HK;
    Cancer Lett; 2006 May; 236(2):191-7. PubMed ID: 16832876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the cyclin D1 polymorphism on lung cancer risk--a meta-analysis.
    Li Y; Zhang S; Geng JX; Yu Y
    Asian Pac J Cancer Prev; 2012; 13(5):2325-8. PubMed ID: 22901215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
    Wang S; Huang Y; Su R; Fang Z; Han M
    Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.